Beta-2 receptor antagonists for acute traumatic brain injury.

  • Ker K
  • Blackhall K
  • 3


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. Cerebral oedema, the accumulation of fluid within the brain, is believed to be an important contributor to the secondary brain damage that occurs following injury. The release of kinins is thought to be an important factor in the development of cerebral vasogenic oedema and the use of beta-2 receptor antagonists, which prevent the release of these kinins, have been proposed as a potential therapeutic intervention.

Author-supplied keywords

  • Acute Disease
  • Adrenergic beta-2 Receptor Antagonists
  • Brain Edema
  • Brain Edema: drug therapy
  • Brain Injuries
  • Brain Injuries: drug therapy
  • Brain Injuries: mortality
  • Humans
  • Intracranial Pressure
  • Peptides
  • Peptides: therapeutic use
  • Quinolines
  • Quinolines: therapeutic use
  • Randomized Controlled Trials as Topic

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • K Ker

  • K Blackhall

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free